Syed Alam
Internal Medicine · Kansas City, MONPI 1659867786
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,513 of the $6,313 with a category attached, or 87.3%. 26 manufacturers reported payments, led by AbbVie at 29.2% of the total. Reporting peaked in 2023 at $2,457 and has fallen 52.1% since, to $1,177 in 2025. Among internal medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $47.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Cook Incorporated$800
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$512
- Takeda Pharmaceuticals U.S.A., Inc.$421
- Gilead$346
- Ardelyx, Inc.$323
- plus $2K from 20 others
What the payments were for
- Grants$80013%
- Food & beverage$5,51387%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $1,842 |
| Cook Incorporated | 1 | $800 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $512 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $421 |
| Gilead | 3 | $346 |
| Ardelyx, Inc. | 6 | $323 |
| Ipsen Biopharmaceuticals, Inc | 3 | $183 |
| Mallinckrodt Hospital Products Inc. | 5 | $180 |
| Sanofi | 2 | $171 |
| Regeneron Healthcare Solutions, Inc. | 2 | $161 |
| Intercept Pharmaceuticals, Inc. | 4 | $157 |
| Johnson & Johnson | 3 | $147 |
| ERBE USA Inc | 1 | $133 |
| Boston Scientific | 2 | $130 |
| Phathom Pharmaceuticals, Inc. | 4 | $125 |
| Bristol Myers Squibb | 6 | $121 |
| Exelixis Inc. | 1 | $116 |
| Alnylam Pharmaceuticals Inc. | 1 | $112 |
| E.r. Squibb & Sons, L.L.C. | 1 | $96 |
| Aimmune Therapeutics, Inc. | 2 | $67 |
| Ferring Pharmaceuticals Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Pfizer | 2 | $32 |
| Braintree Laboratories, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| AstraZeneca | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,313 in reported general payments places this provider in the 90th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 33 | $386 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $307 |
| Famotidine | 18 | $259 |
| Metformin Hcl ErMetformin Hcl | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Kansas City
- Craig DietzKansas City$226K
- Kevin SuttmoellerKansas City$198K
- Karla Houston-GrayKansas City$24K
- Kehinde MorohunfolaKansas City$16K
- David WiltKansas City$13K
- Jonathan SzetoKansas City$13K
- Timothy SmithSaint Peters$428K
- Vinay KamatSaint Louis$191K
- David PrelutskySaint Louis$182K
- Dima DandachiColumbia$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.